ACHP Statement on Drug Pricing
ACHP released a statement on drug pricing.
ACHP released a statement on drug pricing.
ACHP calls on Congress to curb direct-to-consumer (DTC) drug ad dominance. Patients should be able to access affordable, necessary medications, rather than being swayed by misleading marketing tactics.
ACHP President and CEO Ceci Connolly released a statement in response to CMS’ final CY2026 Medicare Advantage and Part D rule.
ACHP sent a letter to CMS Administrator, Dr. Oz, with proposed legislation.
ACHP is grateful for its longstanding partnership with CMS and congratulates Dr. Mehmet Oz on his confirmation as CMS Administrator.